FindTrial
Sign In

Hepatic protective effect of Dexmedetomidine after partial hepatectomy surgery: a prospective controlled study.

Hepatic protective effect of Dexmedetomidine after partial hepatectomy surgery: a prospective controlled study. - Hepatic protective effect of Dexmedetomidine after partial hepatectomy surgery: a prospective controlled study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031803
Enrollment
50
Registered
2018-03-25
Start date
2016-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CONTROLLED TRIAL

Interventions

dexmedetomidineis dissolved in 0.9% sodium chloride with the concentration of 4 mg ml and infused at 0.3 mg/kg/ h. 0.9% sodium chloride is infused at 4 ml/kg/ h.

Sponsors

MANSOURA FACULTY OF MEDICINE, MANSOURA, EGYPT
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1- ASA II/III 2- planned for partial hepatectomy

Exclusion criteria

Exclusion criteria: 1-patient refusal 2- any renal diseases 3- cardiac ejection fraction less than 40% 4- myocardial infarction within 3 months, or any anginal pain within 48 h 5- fulminant hepatitis 6- pulmonary dysfunction

Design outcomes

Primary

MeasureTime frame
EVALUATION THE PROTECTIVE EFFECT OF DEXMEDETOMEDINE ON HEPATIC FUNCTION AFTER PARTIAL HEPATECTOMY—

Countries

Africa

Contacts

Public ContactHANI IBRAHIM TAMAN

MANSOURA FACULTY OF MEDICINE ANAESTHESIOLOGY DEPARTMENT

hani_taman@yahoo.com020507484774

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026